» Articles » PMID: 16614739

Molecular Virology of Hepatitis C Virus (HCV): 2006 Update

Overview
Journal Int J Med Sci
Specialty General Medicine
Date 2006 Apr 15
PMID 16614739
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Fascinating progress in the understanding of the molecular biology of hepatitis C virus (HCV) was achieved recently. The replicon system revolutionized the investigation of HCV RNA replication and facilitated drug discovery. Novel systems for functional analyses of the HCV glycoproteins allowed the validation of HCV receptor candidates and the investigation of cell entry mechanisms. Most recently, recombinant infectious HCV could be produced in cell culture, rendering all steps of the viral life cycle, including entry and release of viral particles, amenable to systematic analysis. In this review, we summarize recent advances and discuss future research directions.

Citing Articles

Cytoskeletal Vimentin Directs Cell-Cell Transmission of Hepatitis C Virus.

Xing Y, Wen Z, Mei J, Huang X, Zhao S, Zhong J Adv Sci (Weinh). 2024; 12(3):e2408917.

PMID: 39611409 PMC: 11744697. DOI: 10.1002/advs.202408917.


Rapid and Sensitive Detection of Hepatitis C Virus in Clinical Blood Samples Using Reverse Transcriptase Polymerase Spiral Reaction.

Sun W, Du Y, Li X, Du B J Microbiol Biotechnol. 2020; 30(3):459-468.

PMID: 31893596 PMC: 9728396. DOI: 10.4014/jmb.1910.10041.


Celastrol inhibits hepatitis C virus replication by upregulating heme oxygenase-1 via the JNK MAPK/Nrf2 pathway in human hepatoma cells.

Tseng C, Hsu S, Lin C, Wu Y, Lee J, Young K Antiviral Res. 2017; 146:191-200.

PMID: 28935193 PMC: 7113881. DOI: 10.1016/j.antiviral.2017.09.010.


Nonstructural protein 5B promotes degradation of the NORE1A tumor suppressor to facilitate hepatitis C virus replication.

Arora P, Basu A, Schmidt M, Clark G, Donninger H, Nichols D Hepatology. 2017; 65(5):1462-1477.

PMID: 28090674 PMC: 5397368. DOI: 10.1002/hep.29049.


An insight into the molecular characteristics of hepatitis C virus for clinicians.

Du L, Tang H Saudi Med J. 2016; 37(5):483-91.

PMID: 27146609 PMC: 4880646. DOI: 10.15537/smj.2016.5.14178.


References
1.
Tellinghuisen T, Marcotrigiano J, Rice C . Structure of the zinc-binding domain of an essential component of the hepatitis C virus replicase. Nature. 2005; 435(7040):374-9. PMC: 1440517. DOI: 10.1038/nature03580. View

2.
Lohmann V, KORNER F, Dobierzewska A, Bartenschlager R . Mutations in hepatitis C virus RNAs conferring cell culture adaptation. J Virol. 2001; 75(3):1437-49. PMC: 114050. DOI: 10.1128/JVI.75.3.1437-1449.2001. View

3.
Hope R, Murphy D, McLauchlan J . The domains required to direct core proteins of hepatitis C virus and GB virus-B to lipid droplets share common features with plant oleosin proteins. J Biol Chem. 2001; 277(6):4261-70. DOI: 10.1074/jbc.M108798200. View

4.
Watashi K, Ishii N, Hijikata M, Inoue D, Murata T, Miyanari Y . Cyclophilin B is a functional regulator of hepatitis C virus RNA polymerase. Mol Cell. 2005; 19(1):111-22. DOI: 10.1016/j.molcel.2005.05.014. View

5.
Tan S, Katze M . How hepatitis C virus counteracts the interferon response: the jury is still out on NS5A. Virology. 2001; 284(1):1-12. DOI: 10.1006/viro.2001.0885. View